NEW YORK, NY / ACCESSWIRE / October 13, 2024 / If you suffered a loss on your Bumble Inc. (NASDAQ:BMBL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bumble-lawsuit-submission-form?prid=108089&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) […]

NEW YORK, NY / ACCESSWIRE / October 13, 2024 / If you suffered a loss on your Bumble Inc. (NASDAQ:BMBL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bumble-lawsuit-submission-form?prid=108081&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)

NEW YORK, NY / ACCESSWIRE / October 13, 2024 / If you suffered a loss on your Orthofix Medical Inc. (NASDAQ:OFIX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/orthofix-lawsuit-submission-form?prid=108088&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESSWIRE / October 13, 2024 / If you suffered a loss on your Bumble Inc. (NASDAQ:BMBL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bumble-lawsuit-submission-form?prid=108087&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)

NEW YORK, NY / ACCESSWIRE / October 13, 2024 / If you suffered a loss on your Orthofix Medical Inc. (NASDAQ:OFIX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/orthofix-lawsuit-submission-form?prid=108086&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESSWIRE / October 13, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Torrid Holdings Inc. ("Torrid" or the "Company") (NYSE:CURV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Torrid and certain of its officers and/or directors have

SAN DIEGO, Oct. 13, 2024 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that the Symbotic class action lawsuit – captioned Fox v. Symbotic Inc., No. 24-cv-12090 (D. Mass.) – charges Symbotic Inc. (NASDAQ: SYM) as well as certain of Symbotic’s top executives with violations of the Securities Exchange Act of 1934. If

World Winter Sports (Beijing) Expo 2024 Opens On October 11, the Opening Ceremony of World Winter Sports (Beijing) Expo (hereinafter referred to as the “WWSE”) 2024 was held at the Shougang Park in Shijingshan, District, Beijing. The 3-day event features over 400 ice and snow brands from countries including Austria, Italy, Germany, Japan, etc. Officials

Fourth Breakthrough Therapy Designation forsunvozertinib in NSCLC with EGFR exon20ins Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases,announced that the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) has granted Breakthrough Therapy Designation (BTD) for sunvozertinib for the first-line treatment of

The 90th China International Medical Equipment Fair (CMEF) has successfully kicked off in Shenzhen, running from October 12-15. This year’s event spans nearly 200,000 square meters and hosts nearly 4,000 exhibitors with an audience surpassing 200,000 from over 130 countries. During the opening ceremony, Reed Sinopharm Exhibitions (RSE) and the Associationof Private Hospitalsof Malaysia (APHM)